TY - JOUR
T1 - Ultrasonic contrast studies for the detection of cardiac shunts
AU - Valdes-cruz, Lilliam M.
AU - Sahn, David J.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1984
Y1 - 1984
N2 - Contrast echocardiography has achieved importance in the diagnosis of cardiac shunt lesions. The technique provides information about flow patterns and serves as an adjunct to identifying communications that may be too small to image, even with high resolution real time scanning. This report reviews clinical applications and experiences in the use of standard, peripherally injected echocardiographic contrast agents for the detection of atrial septal defect, ventricular septal defect and patent ductus arteriosus. The importance and development of transpulmonary contrast agents capable of crossing the pulmonary capillary bed to opacify the left ventricle are reviewed and experience with a variety of experimental echocardiographic contrast agents is presented. Agents opacifying the left ventricle after intravenous injection are capable of providing direct ultrasonic contrast imaging of congenital left to right shunts. Further, recent experience with an experimental standardized, gas-producing contrast agent in an open chest animal model with an experimentally produced ventricular septal defect suggests that a combination of an experimental right heart agent that produces a measurable and reproducible amount of contrast effect, with a videodensitometric system capable of quantifying both positive and negative contrast effects, may provide an ultrasonic method for evaluating the magnitude of cardiac shunts.
AB - Contrast echocardiography has achieved importance in the diagnosis of cardiac shunt lesions. The technique provides information about flow patterns and serves as an adjunct to identifying communications that may be too small to image, even with high resolution real time scanning. This report reviews clinical applications and experiences in the use of standard, peripherally injected echocardiographic contrast agents for the detection of atrial septal defect, ventricular septal defect and patent ductus arteriosus. The importance and development of transpulmonary contrast agents capable of crossing the pulmonary capillary bed to opacify the left ventricle are reviewed and experience with a variety of experimental echocardiographic contrast agents is presented. Agents opacifying the left ventricle after intravenous injection are capable of providing direct ultrasonic contrast imaging of congenital left to right shunts. Further, recent experience with an experimental standardized, gas-producing contrast agent in an open chest animal model with an experimentally produced ventricular septal defect suggests that a combination of an experimental right heart agent that produces a measurable and reproducible amount of contrast effect, with a videodensitometric system capable of quantifying both positive and negative contrast effects, may provide an ultrasonic method for evaluating the magnitude of cardiac shunts.
UR - http://www.scopus.com/inward/record.url?scp=0021343070&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021343070&partnerID=8YFLogxK
U2 - 10.1016/S0735-1097(84)80356-3
DO - 10.1016/S0735-1097(84)80356-3
M3 - Article
C2 - 6707362
AN - SCOPUS:0021343070
SN - 0735-1097
VL - 3
SP - 978
EP - 985
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 4
ER -